News

The 25th anniversary congress of the Russian Association of Urologists gathered in Kazan more than 4 000 specialists (urologists, andrologists, oncourologists, endocrinologists, nephrologists) from all cities of Russia and neighboring countries from CIS Region. The multidisciplinary approach to the diagnosis and treatment of urological diseases as well as impressive wealth of scientific developments and achievements were in the focus of the congress scientific program.

Aristo Pharma participated with the Blemaren branded booth and various promotional materials presenting key advantages and effectiveness of Aristo Pharma product, extracts from the Russian Clinical Recommendations 2024 and scientific articles on Blemaren, mobile application Blemastone (developed and implemented locally by Aristo Pharma Russia) etc.

Within the plenary session and working groups five reports dedicated to Blemaren had been presented by leading Russian experts in urolithiasis. Thanks to the scale and diversity of the presentations, reports and topics discussed, the participants of the congress were able to have access to latest methods of diagnosing and treating urolithiasis, detailed answers to their questions.

This allowed us not only to share the latest scientific data and results of clinical cases about Blemaren but also to expand the product client base and to strengthen trust and loyalty of the urological community towards the company and the product.

The key goal of Aristo participation in the congress was to confidently move forward to new heights searching and opening new opportunities for well-known Blemaren existed on the Russian pharmaceutical market since 1976.

The comprehensive and interdisciplinary nature of the scientific program covered the most important problems of urology in the context of advanced achievements, including in the field of artificial intelligence, telemedicine and digital technologies. The results of latest fundamental researches in urology, neurourology and related fields, modern approaches to the diagnosis and treatment of urological, andrological, urogynecological, oncourological and endocrine diseases, as well as innovations and startups have been presented. The format of live communication allowed the participants to directly share experiences with colleagues from different countries, gain new knowledge and attend scientific schools led by leading experts in the field.

Source: https://congress-rou.ru/rou2025